Dearborn Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,006
| Closed | -$207K | – | 259 |
|
|
2025
Q2 | $207K | Sell |
3,006
-171
| -5% | -$11.2K | 0.01% | 253 |
|
|
2025
Q1 | $215K | Buy |
+3,177
| New | +$190K | 0.01% | 247 |
|
|
2024
Q4 | – | Sell |
-7,013
| Closed | -$441K | – | 264 |
|
|
2024
Q3 | $441K | Sell |
7,013
-6,273
| -47% | -$366K | 0.02% | 187 |
|
|
2024
Q2 | $785K | Sell |
13,286
-4,123
| -24% | -$258K | 0.03% | 129 |
|
|
2024
Q1 | $1.39M | Buy |
17,409
+1,597
| +10% | +$122K | 0.06% | 102 |
|
|
2023
Q4 | $1.25M | Buy |
15,812
+3,368
| +27% | +$240K | 0.05% | 101 |
|
|
2023
Q3 | $869K | Buy |
12,444
+1,842
| +17% | +$131K | 0.03% | 114 |
|
|
2023
Q2 | $733K | Sell |
10,602
-1,913
| -15% | -$136K | 0.03% | 127 |
|
|
2023
Q1 | $930K | Buy |
12,515
+2,716
| +28% | +$228K | 0.04% | 115 |
|
|
2022
Q4 | $913K | Buy |
9,799
+165
| +2% | +$15.9K | 0.04% | 118 |
|
|
2022
Q3 | $919K | Buy |
9,634
+436
| +5% | +$43.2K | 0.04% | 113 |
|
|
2022
Q2 | $852K | Hold |
9,198
| – | – | 0.04% | 126 |
|
|
2022
Q1 | $931K | Buy |
9,198
+68
| +0.7% | +$7.14K | 0.04% | 126 |
|
|
2021
Q4 | $942K | Sell |
9,130
-770
| -8% | -$71.2K | 0.03% | 124 |
|
|
2021
Q3 | $840K | Sell |
9,900
-77
| -0.8% | -$6.45K | 0.03% | 123 |
|
|
2021
Q2 | $832K | Buy |
9,977
+549
| +6% | +$45K | 0.03% | 126 |
|
|
2021
Q1 | $709K | Buy |
9,428
+1,460
| +18% | +$106K | 0.03% | 127 |
|
|
2020
Q4 | $544K | Sell |
7,968
-714
| -8% | -$46.4K | 0.02% | 145 |
|
|
2020
Q3 | $507K | Sell |
8,682
-1,310
| -13% | -$81.5K | 0.03% | 136 |
|
|
2020
Q2 | $649K | Sell |
9,992
-630
| -6% | -$39.7K | 0.04% | 117 |
|
|
2020
Q1 | $630K | Sell |
10,622
-1,215
| -10% | -$81.1K | 0.04% | 110 |
|
|
2019
Q4 | $879K | Sell |
11,837
-300
| -2% | -$21.1K | 0.04% | 108 |
|
|
2019
Q3 | $765K | Sell |
12,137
-1,919
| -14% | -$114K | 0.04% | 105 |
|
|
2019
Q2 | $766K | Buy |
14,056
+3,411
| +32% | +$184K | 0.05% | 101 |
|
|
2019
Q1 | $574K | Sell |
10,645
-1,381
| -11% | -$85.2K | 0.04% | 108 |
|
|
2018
Q4 | $788K | Sell |
12,026
-138,822
| -92% | -$10.4M | 0.06% | 98 |
|
|
2018
Q3 | $11.9M | Buy |
150,848
+33
| +0% | +$2.36K | 0.83% | 54 |
|
|
2018
Q2 | $9.71M | Sell |
150,815
-5,128
| -3% | -$338K | 0.76% | 56 |
|
|
2018
Q1 | $9.7M | Sell |
155,943
-3,031
| -2% | -$217K | 0.75% | 55 |
|
|
2017
Q4 | $11.5M | Sell |
158,974
-71,816
| -31% | -$5.22M | 0.83% | 54 |
|
|
2017
Q3 | $18.8M | Buy |
230,790
+1,020
| +0.4% | +$80.7K | 1.38% | 30 |
|
|
2017
Q2 | $18.5M | Buy |
229,770
+5,253
| +2% | +$415K | 1.37% | 32 |
|
|
2017
Q1 | $17.6M | Buy |
224,517
+14,868
| +7% | +$1.19M | 1.37% | 34 |
|
|
2016
Q4 | $16.5M | Buy |
209,649
+48,527
| +30% | +$3.93M | 1.38% | 33 |
|
|
2016
Q3 | $14.3M | Buy |
161,122
+7,295
| +5% | +$689K | 1.21% | 38 |
|
|
2016
Q2 | $14.7M | Buy |
153,827
+12,068
| +9% | +$1.2M | 1.28% | 34 |
|
|
2016
Q1 | $14.7M | Buy |
141,759
+9,255
| +7% | +$900K | 1.37% | 32 |
|
|
2015
Q4 | $13M | Buy |
+132,504
| New | +$13M | 1.21% | 34 |
|
Other funds holding CVS
Dearborn Partners's CVS Position: Q3 2025 in Review
Dearborn Partners sold out of CVS Health (CVS) in Q3 2025, closing a stake of 3,006 shares — an estimated $207K sold.
Dearborn Partners first reported a position in CVS in Q4 2015 and held it in 38 quarters. The position peaked at $18.8M in Q3 2017. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.
- Dearborn Partners reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
- Dearborn Partners sold 3,006 CVS Health shares in Q3 2025, an estimated $207K.
- Dearborn Partners first reported a position in CVS Health in Q4 2015 and held it in 38 quarters.
- Dearborn Partners's CVS Health position peaked at $18.8M in Q3 2017.
- 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.
Based on Dearborn Partners's 13F filing for Q3 2025, filed 10 Nov 2025.